A previous study showed that METTL3 was overexpressed in acute myeloid leukemia, in which it methylated BCL2, PTEN, and c-Myc mRNAs, leading to boosted translation and the inhibition of cell apoptosis and differentiation, thereby promoting leukemia progression [114]. This evidence concerns the gene MYC and acute myeloid leukemia.